Copyright
©The Author(s) 2022.
World J Diabetes. Aug 15, 2022; 13(8): 622-642
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.622
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.622
Table 1 Statistical analysis of wound healing rate at different times
Time | 0 d (%) | 3 d (%) | 7 d (%) | 14 d (%) |
Control group | 0 | 10.41 ± 0.24 | 17.43 ± 0.13 | 33.73 ± 0.28 |
Experimental group | 0 | 32.78 ± 0.46 | 38.14 ± 0.28 | 53.11 ± 0.07 |
Homogeneity of variance | — | √ | √ | √ |
P value | — | < 0.05 | < 0.05 | < 0.05 |
Table 2 Gas chromatography–mass spectrometry full spectrum identification results
No. | RT (min) | Relative content (%) | Qualitative | CAS | Name |
1 | 26.36 | 0.59 | 51.56 | 512-61-8 | (-)-α-Santalene |
2 | 27.07 | 0.26 | 25.81 | 87-44-5 | Caryophyllene |
3 | 29.71 | 1.86 | 65.77 | 495-60-3 | α-Zingiberene |
4 | 29.83 | 0.64 | 14.58 | 495-61-4 | 6-methyl-2-(4-methylcyclohex-3-enyl)hept-1,5-diene |
5 | 30.64 | 1.95 | 60.85 | 20307-83-9 | β-Sesquiphellandrene |
6 | 30.7 | 1.33 | 80.1 | 644-30-4 | α-Curcumene |
7 | 34.21 | 0.38 | 26.47 | 56192-70-2 | (Z)-a-Atlantone |
8 | 34.27 | 0.23 | 61.92 | 1139-30-6 | Caryophyllene oxide |
9 | 34.36 | 0.30 | 19.52 | 83173-76-6 | 2-Methyl-1-(4-methylphenyl)-3-buten-1-ol |
10 | 34.52 | 0.25 | 58.19 | 108549-47-9 | (6Z)-2-Methyl-6-(4-methyl-3-cyclohexen-1-ylidene)-2-hepten-4-one |
11 | 35.47 | 0.58 | 29.36 | 639-99-6 | Elemol |
12 | 35.78 | 0.28 | 58.71 | 145512-84-1 | Trans-Sesquisabinene hydrate |
13 | 36 | 0.37 | 62.02 | 58334-55-7 | Zingiberenol |
14 | 36.57 | 0.74 | 86.3 | 6989-21-5 | Atractylon |
15 | 36.83 | 0.25 | 12.5 | 82508-14-3 | 2-methyl-6-(4-methylidenecyclohex-2-en-1-yl)hept-2-en-4-one |
16 | 37.23 | 0.77 | 22.65 | 1209-71-8 | γ-Eudesmol |
17 | 37.41 | 20.74 | 91.81 | 180315-67-7 | Tumerone |
18 | 37.67 | 13.80 | 22.04 | 1460-73-7 | Agarospirol |
19 | 37.81 | 1.75 | 38 | 112-39-0 | Methyl palmitate |
20 | 38.41 | 1.26 | 41.2 | 473-16-5 | a-Eudesmol |
21 | 38.48 | 0.72 | 9.97 | 515-20-8 | Costol |
22 | 38.65 | 9.06 | 76.48 | 473-15-4 | β-Eudesmol |
23 | 39.1 | 24.33 | 97.75 | 532-65-0 | ar-Turmerone |
24 | 39.28 | 0.24 | 11.67 | 19888-00-7 | 4,8-Cycloundecadien-1-ol, 6,6,9-trimethyl-2-methylene-, (1R,4E,8E)- |
25 | 39.47 | 0.23 | 4.42 | 65646-68-6 | N-(4-hydroxyphenyl)retinamide |
26 | 39.64 | 0.39 | 8.22 | 19912-67-5 | (+)-Epicubenol |
27 | 39.9 | 0.85 | 49.47 | 30666-87-6 | 2-Methyl-6-(4-methylphenyl)-4-heptanone |
28 | 40.16 | 1.05 | 49.07 | 72441-71-5 | (6R,7R)-Bisabolone |
29 | 40.53 | 2.23 | 89.2 | 108645-54-1 | (E)-Atlantone |
30 | 40.89 | 0.65 | 82.79 | 120681-80-3 | 2-Cyclohexene-1-propanol,g-methyl-4-methylene-a-(2-methyl-1-propen-1-yl) |
31 | 41.58 | 0.45 | 75.15 | 112-61-8 | Octadecanoic acid, methyl ester |
32 | 41.88 | 1.87 | 16.03 | 112-62-9 | Methyl oleate |
33 | 41.98 | 0.65 | 7.88 | 1937-62-8 | trans-octadec-9-enoicacidmethylester |
34 | 42.55 | 1.03 | 26.03 | 112-63-0 | methyl linoleate |
35 | 43.54 | 0.42 | 42.85 | 301-00-8 | 9,12,15-Octadecatrienoic acid, methyl ester |
36 | 43.61 | 0.22 | 4.63 | 29550-55-8 | Teresantalol(7CI) |
37 | 44.58 | 0.24 | 88.5 | 69301-27-5 | 2-(1,5-Dimethyl-4-Hexenyl)-5-Methyl-Phenol |
38 | 43.85 | 0.84 | 6.23 | 38142-57-3 | 2-Methyl-6-(p-tolyl)hept-2-en-4-ol |
39 | 45.01 | 1.11 | 28.14 | 3218-36-8 | 4-Biphenylcarboxaldehyde |
40 | 46.86 | 0.84 | 75.64 | 4666-84-6 | Proximadiol |
41 | 47.75 | 0.46 | 98.07 | 949081-10-1 | (S)-3-Methyl-6-((S)-6-methyl-4-oxohept-5-en-2-yl)cyclohex-2-enone |
42 | 48.71 | 0.24 | 9.54 | 2566-90-7 | Methyl 4,7,10,13,16,19-cis-docosahexanenoate |
43 | 51.08 | 2.31% | 83.12 | 1957-10-3 | Palmitic acid |
Table 3 Ultra-performance liquid chromatography full spectrum identification results
No. | Name | CAS | Molecular weight | RT (min) | Relative concentration (μg/mL) |
1 | DL-Arginine | 7200-25-1 | 174.11175 | 0.783 | 24.44253696 |
2 | Nitrosobis(2-oxopropyl)amine | 60599-38-4 | 158.06914 | 0.817 | 15.74503993 |
3 | Gluconic acid | 526-95-4 | 196.05765 | 0.821 | 82.48616363 |
4 | D-(+)-Proline | 344-25-2 | 115.06357 | 0.846 | 15.35704499 |
5 | Cabotegravir | 1051375-10-0 | 405.11182 | 0.847 | 20.08010135 |
6 | α,α-Trehalose | 99-20-7 | 342.11623 | 0.847 | 409.0449144 |
7 | D-(-)-Quinic acid | 77-95-2 | 192.06275 | 0.85 | 56.2670819 |
8 | Isocitric acid | 320-77-4 | 192.02637 | 0.939 | 63.29259087 |
9 | Citric acid | 77-92-9 | 192.02637 | 1.169 | 145.2856943 |
10 | Gallic acid | 149-91-7 | 170.02078 | 1.899 | 23.57871448 |
11 | Chlorogenic acid | 327-97-9 | 354.09527 | 5.332 | 44.58986172 |
12 | Catechin | 88191-48-4 | 290.07917 | 5.431 | 98.07463825 |
13 | methyl chlorogenate | 123483-19-2 | 368.11081 | 5.501 | 18.15074983 |
14 | 6-Acetylcodeine | 6703-27-1 | 341.16237 | 5.886 | 12.3548527 |
15 | 2-(3,4-Dihydroxyphenyl)ethyl 3-O-(6-deoxy-β-L-mannopyranosyl)-6-O-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoyl]-β-D-glucopyranoside | 61303-13-7 | 624.20617 | 6.092 | 20.78761602 |
16 | (3R,5R)-1,3,5-Trihydroxy-4-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoyl]oxy}cyclohexanecarboxylic acid | 2613-86-7 | 368.11084 | 6.196 | 201.3429867 |
17 | Emodin-8-Beta-D-Glucoside | 23313-21-5 | 432.10571 | 6.579 | 7.280885459 |
18 | 2-[4-[3-[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-7-hydroxy-2,3-dihydrochromen-4-one | 74639-14-8 | 550.16902 | 6.625 | 13.98565399 |
19 | Baicalin | 21967-41-9 | 446.0852 | 6.663 | 16.85569046 |
20 | Liquiritin | 551-15-5 | 418.12676 | 6.737 | 22.91985259 |
21 | Naringin | 10236-47-2 | 580.17964 | 6.959 | 26.36327029 |
22 | Hesperidin | 520-26-3 | 610.19038 | 7.191 | 85.82076776 |
23 | Azelaic acid | 123-99-9 | 188.1042 | 7.548 | 4.773123466 |
24 | Berberine | 2086-83-1 | 335.11525 | 8.242 | 232.2489146 |
25 | isosakuranetin-7-O-rutinoside | 14259-47-3 | 594.19556 | 8.493 | 4.34803523 |
26 | Tinnevellin glucoside | 80358-06-1 | 408.14228 | 8.786 | 13.59498227 |
27 | Daidzein | 486-66-8 | 254.05778 | 9.009 | 13.05981793 |
28 | Chrysophanol 8-O-β-D-glucoside | 13241-28-6 | 416.11099 | 9.01 | 17.88080565 |
29 | Licoricesaponin G2 | 118441-84-2 | 838.39998 | 9.824 | 7.195669531 |
30 | Luteolin | 491-70-3 | 286.04776 | 9.909 | 1.034661042 |
31 | (15Z)-9,12,13-Trihydroxy-15-octadecenoic acid | 95341-44-9 | 330.24071 | 9.938 | 19.41925634 |
32 | Rheic acid | 478-43-3 | 284.03211 | 11.029 | 81.8044913 |
33 | Bisdemethoxycurcumin | 24939-16-0 | 308.10496 | 11.328 | 153.9247824 |
34 | 6-Hydroxy-2-naphthoic acid | 16712-64-4 | 188.04652 | 11.328 | 7.047135466 |
35 | Demethoxycurcumin | 22608-11-3 | 338.11567 | 11.473 | 151.9906609 |
36 | 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one | 76735-58-5 | 370.14168 | 11.541 | 55.08087646 |
37 | Curcumin | 458-37-7 | 368.12606 | 11.619 | 307.1972754 |
38 | Isoimperatorin | 482-45-1 | 270.08918 | 11.847 | 1.025466018 |
39 | Genistein | 446-72-0 | 270.05279 | 12.256 | 153.8276373 |
40 | (+/-)9-HODE | 98524-19-7 | 296.23511 | 13.146 | 23.43829567 |
41 | (+)-ar-Turmerone | 532-65-0 | 216.15135 | 13.605 | 23.84749189 |
42 | Indane | 496-11-7 | 118.07843 | 13.605 | 27.63249372 |
43 | Prespatane | 100387-71-8 | 204.18777 | 13.956 | 2.010509748 |
44 | (+)-Nootkatone | 4674-50-4 | 218.16696 | 14.497 | 16.6606139 |
45 | Aristolone | 6831-17-0 | 218.16696 | 14.588 | 45.88543598 |
46 | 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) | 119-47-1 | 340.24015 | 16.788 | 25.70628216 |
Table 4 Ruyi Jinhuang powder “Chinese medicine-ingredients-target” correspondence
CAS | Name | GenecardID | Attribution |
512-61-8 | (-)-α-Santalene | PTGS2, CHRM2 | JH |
87-44-5 | Caryophyllene | PTGS2, CHRM2 | BZ, JH, CZ, ZHP, TNX |
495-60-3 | α-Zingiberene | PTGS2, DPP4 | JH |
20307-83-9 | β-Sesquiphellandrene | PTGS2 | JH |
644-30-4 | α-Curcumene | PTGS2, TOP2A, DPP4 | JH |
1139-30-6 | Caryophyllene oxide | CHRM2, DPP4 | ZHP, TNX |
639-99-6 | Elemol | CHRM2 | ZHP, JH |
58334-55-7 | Zingiberenol | CHRM2 | JH |
6989-21-5 | Atractylon | SCN5A, CHRM4, HTR2A, CHRM2, OPRM1 | CZ |
82508-14-3 | 2-methyl-6-(4-methylidenecyclohex-2-en-1-yl)hept-2-en-4-one | PTGS2, CHRM2 | JH, ZHP, CZ |
112-39-0 | Methyl palmitate | PTGS2, IL-10, TNF, IL-6 | JH, ZHP, BZ, HB, THF |
473-15-4 | beta-Eudesmol | CHRM2 | ZHP, JH, CZ |
532-65-0 | (6S)-2-methyl-6-(4-methylphenyl)hept-2-en-4-one | DPP4, PTGS2, CHRM2x, ampC | JH |
112-62-9 | Methyl oleate | RXRA | ZHP, THF |
1937-62-8 | trans-octadec-9-enoicacidmethylester | RXRA | ZHP, THF |
112-63-0 | methyl linoleate | PTGS2, RXRA | BZ, THF, ZHP, TNX |
301-00-8 | 9,12,15-Octadecatrienoic acid, methyl ester, (Z,Z,Z)- | PTGS2, RXRA | THF |
38142-57-3 | 2-Methyl-6-(p-tolyl)hept-2-en-4-ol | PTGS2, CHRM2, DPP4, ampC, RXRA | THF, ZHP, TNX |
1957—10—3 | Palmitic acid | PTGS2, IL-10, TNF, PCYT1A | DH, ZHP, THF |
149-91-7 | Gallic acid | PTGS2, PTPN1, TOP2A | DH, TNX, CP, GC, JH |
23313-21-5 | Emodin-8-Beta-D-Glucoside | TOP2A | DH |
458-37-7 | Curcumin | PTGS2, PTPN1 | JH |
22608-11-3 | Demethoxycurcumin | PTGS2, PTPN1, AKR1B1, ABCB1, SCN5A | JH |
520-26-3 | Hesperidin | PTGS2 | CP |
14259-47-3 | isosakuranetin-7-O-rutinoside | TOP2A | CP |
10236-47-2 | Naringin | TOP2A, CDKN1A, TNF, RASGRF2, RAF, PTGS2, ampC, MTTP, APOB, mvaA, PPARA | CP, GC |
21967-41-9 | Baicalin | PTPN1, TOP2A | DH |
88191-48-4 | Catechin | CHRM2 | DH, CP |
491-70-3 | Luteolin | PTGS2, DPP4, EGFR, IL10, CDK4, TNF, IL6, NFKBIA, psdA1, IL2, TOP2A, SLC2A4, INSR, MET | CP, ZHP |
551-15-5 | Liquiritin | PTGS2 | GC |
478-43-3 | Rheic acid | PTGS2, AKR1B1 | DH |
2086-83-1 | Berberine | PTGS2, RXRA | HB |
77-92-9 | Citric acid | PTGS2, AKR1B1, GRIN2A, GRIA2, PTPN1 | DH |
320-77-4 | Isocitric acid | PTGS2 | DH |
7200-25-1 | DL-Arginine | PTGS2 | THF |
446-72-0 | Genistein | PTGS2, EGFR, TNF, SELE, IL8 | GC |
482-45-1 | Isoimperatorin | PTGS2 | BZ |
486-66-8 | Daidzein | PTGS2, RXRA | GC |
6831-17-0 | Aristolone | CHRM2, PTGS2 | BZ |
532-65-0 | (+) -ar-Turmerone | PTGS2, RXRA, CHRM2, ampC, DPP4 | JH |
327-97-9 | Chlorogenic acid | PTGS2 | HB |
77-95-2 | D-(-)-Quinic acid | PTGS2 | HB |
1460-73-7 | Agarospirol | CHRM2 | ZHP |
Table 5 Docking parameters of chemical components and target protein molecules
Name | Target | LibDockScore |
Luteolin | TOP2A | 104.333 |
Methyl palmitate | PTGS2 | 114.221 |
ar-Turmeric | PTGS2 | 91.0625 |
CHRM2 | 88.3765 | |
Methyl Linoleate | RXRA | 138.583 |
PTGS2 | 130.838 | |
Palmitic acid | PTGS2 | 114.349 |
Demethoxycurcumin | PTGS2 | 135.479 |
Naringin | TOP2A | 141.197 |
PTGS2 | 164.305 |
- Citation: Li XY, Zhang XT, Jiao YC, Chi H, Xiong TT, Zhang WJ, Li MN, Wang YH. In vivo evaluation and mechanism prediction of anti-diabetic foot ulcer based on component analysis of Ruyi Jinhuang powder. World J Diabetes 2022; 13(8): 622-642
- URL: https://www.wjgnet.com/1948-9358/full/v13/i8/622.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i8.622